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CASE REPORT
Pseudomonas aeruginosa SEPTIC SHOCK ASSOCIATED WITH ECTHYMA GANGRENOSUM
IN AN INFANT WITH AGAMMAGLOBULINEMIA
João Fernando Lourenço de ALMEIDA, Jaques SZTAJNBOK, Eduardo Juan TROSTER & Flávio Adolfo Costa VAZ
SUMMARY
Ecthyma gangrenosum (EG) due to Pseudomonas aeruginosa is a rare and invasive infection that can be associated with
agammaglobulinemia. The cornerstone of the treatment is based on prompt recognition with appropriate antibiotic coverage and
intravenous immunoglobulin. The authors report a case of EG emphasizing the clinical and therapeutic aspects of this condition.
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INTRODUCTION
Ecthyma Gangrenosum (EG) is a characteristic dermatologic
manifestation of severe and invasive infection caused most commonly
by P. aeruginosa2. This disease has been related to life-threatening
septicemic infections and high mortality6,7,9. The most important
predisposing factor that can lead to EG is the presence of any kind of
immunodeficiency associated with severe neutropenia1,6,7,14. One of the
major examples of this condition is found in patients with
agammaglobulinemia or hypogammaglobulinemia who manifest this
association. Once considered unusual, EG has received special attention
in the medical literature in recent years2,3,9,10,14,15. Herein we describe a
case of EG caused by P. aeruginosa in an infant, the diagnosis of which
lead to the recognition of a previously unknown agammaglobulinemia.
CASE REPORT
A nine-month-old white Brazilian female was admitted to the
emergency department after experiencing five days of left otorrhea and
two days of a vulvar necrotic lesion. On physical examination, she was
well developed with a toxemic appearance, presenting with fever,
tachicardia, tachipnea and hypotension. A single vulvar skin lesion was
present which began as a pink macule and progressed in hours to a
necrotic lesion with scar formation, surrounded by an intense red areola.
Other lesions with the same aspect was disseminated on the thoracic
region and lower extremities (Fig. 1 and 2). The laboratory findings
were: peripheral WBC count 1600 mm3 of which 0% were neutrophils,
64% were lymphocytes, and 32% were monocytes; hemoglobin 8.5g/
dL and platelets 243 x 103/L; C-reactive protein was 190 mg/dL;
metabolic acidosis, hypokalemia and hyponatremia were also present.
The second peripheral WBC count was 22200 mm3 (23% neutrophils,
61% lymphocytes, 6% eosinophils and 10% monocytes).
She was transferred to the Pediatric Intensive Care Unit (PICU) and in
the first eight hours she needed high doses of norepinephrine (up to 3 mcg/
kg/min) and was intubated for mechanical ventilatory support. The antibiotic
treatment was initiated with intravenous imipenem, amikacin and
clindamycin. During the second PICU day, the infant underwent surgical
debridement of the necrotic lesion (Fig. 3), and due to the severe evolution
and marked neutropenia, a complete workup for immunodeficiency was
made in association with the empirical use of human immunoglobulin 400
mg/kg/dose (three days) and filgrastim (GMSF) 5 mcg/kg/dose.
The bone marrow analysis was normal and the HIV virologic test
was negative. The serum immunoglobulins were: IgG 36 mg/dL , IgA
9.6 mg/dl, IgM 12.2 mg/dL. Complement components (C3, C4, C h50) and
oxidative response (nitroblue tetrazolium – NBT) were normal. The
number of T-lymphocytes was normal, and the number of circulating B-
lymphocytes (CD19, CD20) was less than 1% (measured by flow
cytometry).
After the empirical use of immunoglobulin and GMSF, the peripheral
WBC count increased to 35800 mm3 (fourth PICU day) and serum IgG
to 443 mg/dL and 696 mg/dL (20th and 30th PICU days, respectively).
Pseudomonas aeruginosa was isolated from two blood samples from
the necrotic-pustular skin lesion and from the surgical sample. The infant
underwent a second debridement and a plastic surgical correction in the
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Fig. 3 - Right inguinal aspect after surgical debridement of the necrotic lesion.
Fig. 1 and 2 - Necrotic lesion on the thoracic region and inferior extremities.
DISCUSSION
Pseudomonas aeruginosa generally causes infection in patients with
immunodeficiency conditions2. Hence, the presence of P. aeruginosa
infection in healthy and out-of-hospital children (that was presumably
our patient’s situation on admission) is very uncommon.
One manifestation considered by some authors as characteristic of
P. aeruginosa septicemia is the skin lesion called ecthyma gangrenosum
(EG). This lesion represents a formidable skin sign of a potentially life-
threatening systemic infection, and it is commonly caused by P.
aeruginosa. The characteristic clinical appearance is red maculae that
progress to a hemorrhagic bluish bullae that rupture to form a central
area of necrosis surrounded by an erythematous halo. The main site of
EG lesions is the gluteal or perineal region (57%), although this lesion
can spread to other body sites as occurred in our patient, in which
metastatic lesions appeared on both trunk and lower extremities. One
major clinical feature in almost all patients is the presence of neutropenia.
In two retrospective studies, all the patients with EG were immuno-
compromised leading to severe neutropenia, and the absolute neutrophil
count of less than 500/mm3 were strongly related to the clinical
outcome4,6,7,11,12.
In our patient, the diagnosis of agammaglobulinemia was confirmed
by her extremely low concentration of all the immunoglobulin isotypes,
profound decrease in circulating B-lymphocytes, normal lymphocyte
count and normal cell-mediated immunity, complement, and
phagocytosis. In agammaglobulinemia, the presenting infection is sepsis
(10%), and half of these cases are caused by Pseudomonas species8. In
our hospital, five of nine patients had sepsis as the initial manifestation
of the disease, and 60% were caused by Pseudomonas5.
perineal region. She was discharged after 40 days receiving intravenous
immunoglobulin (400 mg/kg/month) in order to keep IgG > 500 mg/dl
and normal lymphocytes count.
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The association of these four components: sepsis, EG, P. aeruginosa,
and agammaglobulinemia was first described by SPEIRS et al. in 1963
and other authors have also described this rare condition3,9,10,13,14,15. To
decrease the mortality of this condition, the treatment should include
prompt recognition of the skin lesion, appropriate antibiotic coverage,
and surgical debridement. Another therapeutic intervention in our case
was the empirical use of intravenous immunoglobulin, and its use in this
case might be related to the positive outcome of our patient. This
successful empirical intervention has been previously reported in
children9.
With these considerations, we conclude that physicians must be aware
of these conditions and consider EG as a likely diagnosis when facing a
previously healthy septic infant with skin lesions such as those described
above. In this situation, prompt debridement, and initiation of antibiotics
with appropriate coverage against Pseudomonas sp. should be initiated.
If the infant is also neutropenic, an underlying immunodeficiency should
be investigated and empirical therapy with IV immunoglobulin should
be started based on the increased likelihood of an underlying
agammaglobulinemia in patients who present such an association.
RESUMO
Choque séptico por Pseudomonas aeruginosa associado a éctima
gangrenosa em criança com agamaglobulinemia
Éctima Gangrenosa (EG) por Pseudomonas aeruginosa é uma
infecção rara e invasiva que pode ser associada com agamaglobulinemia.
O tratamento fundamental é baseado no pronto reconhecimento com
cobertura de antibiótico apropriada e imunoglobulina intravenosa. Os
autores relatam caso de EG dando ênfase aos aspectos clínicos e
terapêuticos desta condição.
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